Andrew T. SCHIEBER,Charles L. EUTENEUER,David T. VAN METER,Kenneth M. GALT
申请号：
US16061671
公开号：
US20180369017A1
申请日:
2016.12.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
An illustrative method for reducing intraocular pressure in a patient may comprise deploying an ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye and administering a therapeutic agent comprising a Rho kinase (ROCK) inhibitor to the patient. The ocular implant may be configured to lower the intraocular pressure from an initial to a second pressure within a first range and the therapeutic agent may lower an intraocular pressure to a third pressure within a second range, the third pressure lower than the second pressure.
